Carcinoid

Initial Workup

• CT or MRI of Abdomen and Pelvis
• CT of chest if appropriate
• Somatostatin (Octreoscan) scintigraphy (nuclear scan)

Surveillance Imaging

Local or regional disease

• CT or MRI of Abdomen and Pelvis at least 3 months after treatment, then every 6 – 12 months for 10 years as clinically indicated

Metastatic Disease

Asymptomatic

• scans every 3 – 12 months

Rectal Tumors

• Less than 1 cm require no follow up
• 1 - 2 cm rectal MRI at 6 and 12 months, then as clinically indicated
• Greater than 2cm CT or MRI of Abdomen and Pelvis at least 3 months after treatment, then every 6 – 12 months for 10 years

References

• NCCN Guidelines Cacrinoid Tumors v 1.2012 accessed 1/03/12
• Ganeshan D, Bhosale P, Yang T, Kundra V; Imaging features of carcinoid tumors of the gastrointestinal tract; AJR Am J Roentgenol. 2013 Oct;201(4):773-86.
• Dromain C, de Baere T, et al; Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol. 2005;23(1):70.
• NCCN Guidelines Version 1.2015 Neuroendocrine Tumors of the Gastrointestinal Tract, Lung and Thymus (Carcinoid Tumors)